A thorough understanding of the mechanisms underlying the increase in TB-associated cell subsets, such as tissue-resident CD4 T cells and microglia, is expected to lead to new opportunities for therapeutic and diagnostic interventions in TBM. This evidence concerns the gene CD4 and tuberculosis.